Showing results (1501-1510 of 1,615) with videos related to

Sort By:
Pageof 162
Human & Experimental Toxicology|November 27, 2013
Oxidative stress on cardiotoxicity after treatment with single and multiple doses of doxorubicinM Pacifico de Freitas Segredo, D M Favero Salvadori, N S Rocha, et al.
Journal of Medicinal Chemistry|August 21, 2007
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding siteDouglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, et al.
British Journal of Cancer|May 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsGiovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, et al.
Inhalation Toxicology|May 23, 2009
Activity of ectonucleotidases and adenosine deaminase in rats exposed to cigarette smokeG R Thomé, C M Mazzanti, M Ahmed, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2018
Obfuscating transparency?Michael Aschner, Herman Autrup, Colin L Berry, et al.
Infection|February 7, 2024
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge-ORCHESTRA projectGianluca Spiteri, Marika D'Agostini, Mahsa Abedini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2019
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studiesF Marmorino, D Rossini, S Lonardi, et al.
The Journal of Investigative Dermatology|February 21, 2021
Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic ApproachKevin B Kim, Liliana Soroceanu, David de Semir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE StudyCarlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
Molecular & Cellular Proteomics : MCP|June 29, 2021
A Reductionist Approach Using Primary and Metastatic Cell-Derived Extracellular Vesicles Reveals Hub Proteins Associated with Oral Cancer PrognosisAriane Fidelis Busso-Lopes, Carolina Moretto Carnielli, Flavia Vischi Winck, et al.
Pageof 162